Clinical Trials Logo

Clinical Trial Summary

The implications of the medico-economic impact are essential in the choice of first-line therapists. The economic impact is an important criterion to recommend the privileged use of Direct Oral Anticoagulants (AOD) in first intention.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03887806
Study type Observational
Source University Hospital, Strasbourg, France
Contact Dominique STEPHAN, MD, PhD
Phone 33.3.69.55.09.52
Email dominique.stephan@chru-strasbourg.fr
Status Recruiting
Phase
Start date March 20, 2019
Completion date March 20, 2020

See also
  Status Clinical Trial Phase
Completed NCT04414332 - Registry of Angiovac Procedures In Detail Outcomes Database-RAPID Registry
Recruiting NCT03206372 - Risk Factors of Venous Thromboembolism in Women During Hormonal Exposure
Recruiting NCT03937583 - Screening for Cancer in Patients With Unprovoked VTE Phase 4
Not yet recruiting NCT02188056 - Observational Prospectif Monocentric Registry of Patients Suffering From VIE N/A
Completed NCT04846725 - Predictors of Attempted Inferior Vena Cava Filters Retrieval.
Completed NCT01729559 - Venous Thromboembolic Prophylaxis After Major Trauma: A Trial of Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin Phase 4
Completed NCT01466426 - The Role of FDG-PET/CT Imaging in the Management of Patients With Thromboembolic Disorders (The PETVET Study) N/A
Recruiting NCT05150314 - Comparative Study of the Hemorrhagic Risk in Patients Over 75 Years of Age Taking Enoxaparin
Active, not recruiting NCT05396157 - Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective Study
Active, not recruiting NCT00691470 - Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation Phase 2/Phase 3
Completed NCT04824118 - Clotting Parameters After Medical Abortion
Not yet recruiting NCT06232551 - Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism N/A
Recruiting NCT05993533 - Comparison of the 'CTR' Ratio With Standard Haemostasis Parameters in the Follow-up of Patients Undergoing Heparin Therapy
Not yet recruiting NCT05515549 - Value of D-dimer Combined With Other Thrombus Molecular Markers in Risk Assessment of VTE in Hospitalized Patients
Recruiting NCT04211181 - CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism N/A
Completed NCT04818151 - Anticoagulation Strategies for Acute Venous Thromboembolism in Patients With End-Stage Renal Disease Using USRDS Data
Recruiting NCT05089227 - Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study Phase 2
Completed NCT03894878 - Association Between Genetic Variant Scores and Warfarin Effect
Completed NCT00556426 - Prospective, Multi-center, Single-arm Study to Assess the Safety of Retrieval of the Recovery G2 Filter. N/A
Not yet recruiting NCT04158973 - CHIPs-VTE Study in Hospitalized Patients With Lung Cancer N/A